In extreme instances, orthopedic diseases can even result in life-threatening complications
However, there is currently no FDA-approved indication for GLP-1 receptor agonists specifically for inflammation, and the optimal dosing strategy for anti-inflammatory effects has not been established through rigorous clinical trials
Stegenga, H., Haines, A., Jones, K
Side effects and dropouts The trial wasnt without drawbacks
From all similar product I used to date, I am sure there is no better product on the market
Serious hypersensitivity, acute kidney injury from dehydration, and diabetic retinopathy considerations are also documented in the label